510. Real-world Effectiveness of Sotrovimab for COVID-19: Evidence from United States (US) Administrative Claims Data

BACKGROUND: This study compared outcomes among COVID-19 patients (pts) treated with the monoclonal antibody (mAb) sotrovimab matched to untreated pts. METHODS: Administrative claims (Komodo Health) were used to identify pts (≥ 12 years) diagnosed with COVID-19 (ICD-10: U0.7.1) in an ambulatory setti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Christopher F, Lokhandwala, Tasneem, Gibbons, Daniel C, Drysdale, Myriam, Wang, Jane, Lloyd, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679072/
http://dx.doi.org/10.1093/ofid/ofad500.579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679072/
http://dx.doi.org/10.1093/ofid/ofad500.579

Ejemplares similares